Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 04, 2008. The document serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in the company's American Depositary Shares (ADSs).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of insider trading activity and does not contain financial performance data.
Material Changes
The filing details the sale of ADSs by PDMR W.C. Louv on November 04, 2008. The transactions are as follows:
- 362 ADSs sold at $39.7701
- 1,738 ADSs sold at $39.7801
- 400 ADSs sold at $39.7800
Total ADSs sold: 2,500.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory notification of the director's share transactions in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Points
- Verify the total volume of ADSs sold by W.C. Louv (2,500 shares) against the company's insider trading policy.
- Confirm the transaction prices ($39.77 - $39.78) against the market price of GSK ADSs on November 04, 2008.
- Note that this filing contains no financial results; investors should refer to the most recent Form 20-F or quarterly reports for financial performance.